Terapi Toksin Botulinum untuk Alopesia Androgenik: Sebuah Tinjauan Meta-Analisis

Authors

  • Wieka Budhiwidayanti Universitas Sebelas Maret & Rumah Sakit Umum Daerah Dr. Moewardi Surakarta
  • Prasetyadi Mawardi Universitas Sebelas Maret & Rumah Sakit Umum Daerah Dr. Moewardi Surakarta

Keywords:

alopesia androgenik, meta-analisis, pertumbuhan rambut, tinjauan sistematis, toksin botulinum

Abstract

Alopesia androgenik (AGA) adalah kondisi kerontokan rambut progresif non-scarring dengan terapi standar yang terbatas. Toksin botulinum tipe A (BTX-A) telah muncul sebagai pilihan terapi baru. Tinjauan sistematis dan meta-analisis ini bertujuan untuk mengevaluasi kemanjuran dan keamanan BTX-A sebagai monoterapi atau pengobatan adjuvan untuk AGA. Tinjauan sistematis ini mengikuti pedoman PRISMA. Pencarian pada basis data PubMed, ScienceDirect, dan Scopus dilakukan untuk studi yang diterbitkan antara tahun 2020 dan 2025. Populasi target adalah pasien dengan AGA. Variabel independen adalah injeksi BTX-A, dan variabel dependen adalah jumlah rambut, kepadatan, dan perbaikan klinis. Kualitas artikel dinilai menggunakan daftar periksa Joanna Briggs Institute, dan data dianalisis menggunakan meta-analisis model efek acak (random-effects). Enam studi yang terdiri dari 217 pasien memenuhi kriteria kelayakan. Kombinasi BTX-A dengan minoksidil topikal menunjukkan perbaikan klinis yang signifikan pada bulan ke-4 dibandingkan dengan monoterapi minoksidil (SMD = 1.19; 95% CI = 0.65 hingga 1.73; p<0.001). Kombinasi BTX-A dengan finasterid oral menghasilkan jumlah rambut yang secara signifikan lebih besar pada bulan ke-12 dibandingkan monoterapi BTX-A (SMD = -0.54; 95% CI = -1.04 hingga -0.03; p=0.036). Konsentrasi BTX-A yang lebih tinggi (33.30 U/mL) dikaitkan dengan peluang kemunculan rambut vellus yang secara signifikan lebih besar pada bulan ke-3 (OR = 57.70; 95% CI = 9.60 hingga 347.60; p<0.001) dibandingkan dengan konsentrasi yang lebih rendah (25 U/mL). Namun, monoterapi BTX-A tidak menunjukkan perbedaan yang signifikan dalam jumlah rambut dibandingkan dengan plasebo pada bulan ke-3 (SMD = -0.16; 95% CI = -0.68 hingga 0.35; p=0.531). Tidak ada kejadian efek samping serius yang dilaporkan. Toksin botulinum tipe A adalah pilihan terapi yang aman dan efektif untuk alopesia androgenik, khususnya sebagai pengobatan adjuvan yang dikombinasikan dengan standar minoksidil atau finasterid. Terapi ini dapat diintegrasikan ke dalam protokol klinis untuk kerontokan rambut refrakter.

References

Bajoria, P.S., Dave, P.A., Rohit, R.K., Tibrewal, C., Modi, N.S., Gandhi, S.K., Patel, P., 2023. Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials. Cureus. https://doi.org/10.7759/cureus.42768

Cheng, F., Cai, X., Zhang, Y., Wu, J., Yin, S., 2025. Effects and Safety of Botulinum Toxin Injection in Treatment of Androgenetic Alopecia: A Meta-analysis and Systematic Review. Dermatologic Surgery 51, e5–e9. https://doi.org/10.1097/DSS.0000000000004557

Devjani, S., Ezemma, O., Kelley, K.J., Stratton, E., Senna, M., 2023. Androgenetic Alopecia: Therapy Update. Drugs 83, 701–715. https://doi.org/10.1007/s40265-023-01880-x

Di Pietro, A., Piraccini, B.M., 2016. Frontal Alopecia after Repeated Botulinum Toxin Type A Injections for Forehead Wrinkles: An Underestimated Entity? Skin Appendage Disord. 2, 67–69. https://doi.org/10.1159/000448380

English Jr., R.S., Ruiz, S., 2022. Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review. Skin Appendage Disord. 8, 93–100. https://doi.org/10.1159/000518574

Escamilla-Cruz, M., Magaña, M., Escandón-Perez, S., Bello-Chavolla, O.Y., 2023. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. Dermatol. Ther. (Heidelb). 13, 1721–1731. https://doi.org/10.1007/s13555-023-00974-4

Hu, L., Dai, Y., Zhang, H., Wu, Y., Wang, T., Song, X., 2024. Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss. Skin Res. Technol. 30, e13696. https://doi.org/10.1111/srt.13696

Jedlowski, P.M., Anthony, M., 2023. Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Lasers Med. Sci. 39, 4. https://doi.org/10.1007/s10103-023-03946-4

Kaiser, M., Abdin, R., Gaumond, S.I., Issa, N.T., Jimenez, J.J., 2023. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clin. Cosmet. Investig. Dermatol. Volume 16, 1387–1406. https://doi.org/10.2147/CCID.S385861

Kidangazhiathmana, A., Santhosh, P., 2022. Pathogenesis of Androgenetic Alopecia. Clinical Dermatology Review 6, 69–74. https://doi.org/10.4103/cdr.cdr_29_21

Legiawati, L., Suseno, L.S., Sitohang, I.B.S., Pratama, A.I., 2022. Hair disorder in dr. Cipto Mangunkusumo cosmetic dermatology and venereology outpatient clinic of Jakarta, Indonesia: A socio-demographic and clinical evaluation. Dermatol. Reports 14. https://doi.org/10.4081/dr.2022.9341

Lewandowski, M., Świerczewska, Z., Barańska-Rybak, W., 2022. Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art. Molecules 27, 3143. https://doi.org/10.3390/molecules27103143

Li, J., Zhang, S., Zhao, W., Yang, F., Liu, M., Li, X., Jiang, X., 2024. Intradermal Injection in Balding Region Versus Intramuscular Injection in Surrounding Muscles: A Split-Scalp, Randomized Trial on BoNT for Androgenetic Alopecia. Dermatol. Ther. (Heidelb). 14, 1671–1682. https://doi.org/10.1007/s13555-024-01189-x

Li, L., Ma, Q., Luo, W., Ji, J., Zhang, X., Hong, D., 2024. Efficacy of type A botulinum toxin treatment for androgenetic alopecia using ultrasound combined with trichoscopy. Skin Research and Technology 30. https://doi.org/10.1111/srt.13803

Lima-Galindo, A.A., Ocampo-Garza, S.S., Ocampo-Candiani, J., Tosti, A., Sarahi Guerra-Garza, A., Ocampo-Garza, J., 2025. Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial. Actas Dermosifiliogr. 116, 959–966. https://doi.org/10.1016/j.ad.2025.01.012

Łukasik, A., Kozicka, K., Kłosowicz, A., Jaworek, A., Wojas-Pelc, A., 2020. The role of family history and its influence on the onset time in female pattern hair loss. Advances in Dermatology and Allergology. https://doi.org/10.5114/ada.2020.100745

Melo, D.F., Müller-Ramos, P., Cortez de Almeida, R.F., Machado, C.J., Frattini, S., Donda, A.L.V., Antelo, D.A.P., Barcaui, C.B., 2024. Efficacy of botulinum toxin in male androgenetic alopecia: A triple-blind, randomized clinical trial. J. Am. Acad. Dermatol. 91, 996–998. https://doi.org/10.1016/j.jaad.2024.07.1464

Oiwoh, S.O., Enitan, A.O., Adegbosin, O.T., Akinboro, A.O., Onayemi, E.O., 2024. Androgenetic Alopecia: A Review. Nigerian Postgraduate Medical Journal 31, 85–92. https://doi.org/10.4103/npmj.npmj_47_24

Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., Brennan, S.E., Chou, R., Glanville, J., Grimshaw, J.M., Hróbjartsson, A., Lalu, M.M., Li, T., Loder, E.W., Mayo-Wilson, E., McDonald, S., McGuinness, L.A., Stewart, L.A., Thomas, J., Tricco, A.C., Welch, V.A., Whiting, P., Moher, D., 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https://doi.org/10.1136/bmj.n71

Perez, S.M., AlSalman, S.A., Nguyen, B., Tosti, A., 2025. Botulinum Toxin in the Treatment of Hair and Scalp Disorders: Current Evidence and Clinical Applications. Toxins (Basel). 17, 163. https://doi.org/10.3390/toxins17040163

Pham, C. T., Juhasz, M., Ekelem, C., Conic, R. R. Z., Hashemi, K., Csuka, D., Csuka, E., Chao, T., & Mesinkovska, N. A. (2022).

The Association of Frontal Alopecia with a History of Facial and Scalp Surgical Procedures. Skin Appendage Disorders, 8(1), 13–19.

DOI: 10.1159/000518156.

Ramírez-Marín, H., Tosti, A., 2022. Role of oral minoxidil in patterned hair loss. Indian Dermatol. Online J. 13, 729. https://doi.org/10.4103/idoj.idoj_246_22

Rao, A.K., Sobel, J., Chatham-Stephens, K., Luquez, C., 2021. Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR. Recommendations and Reports 70, 1–30. https://doi.org/10.15585/mmwr.rr7002a1

Sadasivam, I.P., Sambandam, R., Kaliyaperumal, D., Dileep, J.E., 2024. Androgenetic Alopecia in Men: An Update On Genetics. Indian J. Dermatol. 69, 282–282. https://doi.org/10.4103/ijd.ijd_729_23

Seoudy, W.M., Metwally, O.A., Elfangary, M.M., Mohamed, T.M., 2024. Assessment of efficacy of different botulinum toxin A concentrations in the treatment of androgenetic alopecia assessed by dermoscopy. J. Cosmet. Dermatol. 23, 417–425. https://doi.org/10.1111/jocd.15972

Singh, S., Neema, S., Vasudevan, B., 2017. A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males. J. Cutan. Aesthet. Surg. 10, 163. https://doi.org/10.4103/JCAS.JCAS_77_17

Sugma, L.A., Yenny, S.W., Rasyid, R., 2023. An overview of risk factors for androgenetic alopecia among women at Pasar Ambacang, Kuranji, Padang. Journal of General - Procedural Dermatology & Venereology Indonesia 7. https://doi.org/10.7454/jdvi.v7i1.1138

Tian, K., Gao, S., Jia, Z., Xu, W., Li, K., Wu, L., 2022. A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia. J. Cosmet. Dermatol. 21, 5584–5590. https://doi.org/10.1111/jocd.15179

Welc, N., Olejniczak, R., Jałowska, M., 2024. The use of botulinum toxin in the treatment of androgenetic alopecia. Forum Dermatologicum 10, 101–103. https://doi.org/10.5603/fd.100354

Wijaya, H., Winaya, K.K., 2021. Androgenetic alopecia in woman treated with botulinum toxin. Intisari Sains Medis 12, 1050–1053. https://doi.org/10.15562/ism.v12i3.1205

Yu, L., Moorthy, S., Li, X., Peng, L., Zhang, Z., Shen, L., Han, Y., Huang, X., 2024. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial. Arch. Dermatol. Res. 316, 532. https://doi.org/10.1007/s00403-024-03258-9

Yu, L., Moorthy, S., Li, X., Peng, L., Zhang, Z., Shen, L., Han, Y., & Huang, X. (2024). Assessing the efficacy and quality of life improvements of botulinum toxin type A with topical minoxidil versus topical minoxidil in male androgenetic alopecia: A randomized controlled trial. Archives of Dermatological Research, 316, 532. https://doi.org/10.1007/s00403-024-03258-9

Zhou, Y., Yu, S., Zhao, J., Feng, X., Zhang, M., Zhao, Z., 2020. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia. Biomed Res. Int. 2020. https://doi.org/10.1155/2020/1501893

Downloads

Published

2026-10-20

How to Cite

Budhiwidayanti, W., & Mawardi , P. (2026). Terapi Toksin Botulinum untuk Alopesia Androgenik: Sebuah Tinjauan Meta-Analisis. Jurnal Ilmiah Permas: Jurnal Ilmiah STIKes Kendal , 16(4), 591–602. Retrieved from https://journal3.stikeskendal.ac.id/index.php/JIPJISK/article/view/316

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.